A single blind randomized controlled clinical trial of mexiletine in amyotrophic lateral sclerosis: Efficacy and safety of sodium channel blocker phase II trial

Kazumoto ShibuyaDepartment of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan

Sonoko MisawaDepartment of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan

Hideki KimuraDepartment of Neurology, Tokyo Metropolitan Neurological Hospital, Fuchu, Tokyo, Japan

Yu-Ichi NotoDepartment of Molecular Neurology and Gerontology, Kyoto Prefectural University of Me1dicine, Kyoto, Japan

Yasunori SatoClinical Research Center, Chiba University Hospital, Chiba, Japan

Yukari SekiguchiDepartment of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan

Yuta IwaiDepartment of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan

Satsuki MitsumaDepartment of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan

Minako BeppuDepartment of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan

Keisuke WatanabeDepartment of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan

Yumi FujimakiDepartment of Neurology, Tokyo Metropolitan Neurological Hospital, Fuchu, Tokyo, Japan

Yukiko TsujiDepartment of Molecular Neurology and Gerontology, Kyoto Prefectural University of Me1dicine, Kyoto, Japan

Toshio ShimizuDepartment of Neurology, Tokyo Metropolitan Neurological Hospital, Fuchu, Tokyo, Japan

Toshiki MizunoDepartment of Molecular Neurology and Gerontology, Kyoto Prefectural University of Me1dicine, Kyoto, Japan

Masanori NakagawaDepartment of Molecular Neurology and Gerontology, Kyoto Prefectural University of Me1dicine, Kyoto, Japan

Kyoko SawaguchiClinical Research Center, Chiba University Hospital, Chiba, Japan

Hideki HanaokaClinical Research Center, Chiba University Hospital, Chiba, Japan

Satoshi KuwabaraDepartment of Neurology, Graduate School of Medicine, Chiba University, Chiba, JapanCorrespondence[email protected]

Articles from other publishers (35)